Ampio Pharmaceuticals, Inc. / Fundamentals
Income statement
- Net revenue
€210.21K - Cost of goods sold
€210.21K - Gross profit
€210.21K - SG&A expenses
€6.07M - R&D expenses
€2.09M - EBITDA
-€8.06M - D&A
-€105.53K - EBIT
-€8.17M - Interest expenses
€259.97K - EBT
-€7.41M - Tax expenses
€157.01K - Net income
-€7.41M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€775.69K - Changes in working capital
€0.00 - Operating cash flow
-€7.35M - Capex
€0.00 - Other investing cash flow
€0.00 - Net investing cash flow
€0.00 - Total cash dividends paid
€0.00 - Issuance of common stock
€84.08K - Debt repayment
€0.00 - Other financing cash flow
€0.00 - Net financing cash flow
€0.00 - Foreign exchange effects
€0.00 - Net change in cash
-€7.35M - Cash at end of period
€3.51M - Free cash flow
-€7.35M
Balance sheet
- Cash and cash equivalents
€3.51M - Cash and short-term investments
€3.51M - Total receivables
€789.36K - Inventory
€0.00 - Other current assets
€623.77K - Total current assets
€4.92M - Property, plant & equipment
€0.00 - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€116.69K - Total non-current assets
€116.69K - Total assets
€4.92M - Accounts payable
€643.50K - Short-term debt
€235.09K - Other current liabilities
€1.14M - Total current liabilities
€2.04M - Long-term debt
€0.00 - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€0.00 - Total liabilities
€2.04M - Common stock
€0.00 - Retained earnings
-€208.09M - Other equity
€0.00 - Total equity
€2.88M - Total liabilities and shareholders' equity
€4.92M
Company information
- Market capitalization
€2.61K - Employees
6 - Enterprise Value
-€3.81M
Company ratios
- Gross margin
-
100.0% Much better than peer group: -980,139,723,341.0% - EBITDA margin
-
-3,835.1% Much better than peer group: -4,765,066,883,465.8% - EBIT margin
-
-3,884.9% Much better than peer group: -4,797,478,466,050.8% - EBT margin
-
-3,523.3% Much better than peer group: -4,721,362,151,951.8% - Net margin
-
-3,523.3% Much better than peer group: -4,721,362,150,460.2% - ROE
-
-256.9% Much better than peer group: -292.8% - ROA
-
-150.5% Much better than peer group: -196.5% - Asset turnover
-
4.3% Even with peer group: 4.7% - FCF margin
-
-3,495.5% Much better than peer group: -4,683,191,035,918.4% - FCF yield
-281,066.9% - Efficiency ratio
3,935.1% - Net sales per employee
-
€35.04K - Net income per employee
-
-€1.23M